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S upraventricular tachyarrhythmia, in contrast to 
arrhythmias in adults, is the most common abnor- 
mal tachycardia in infants and chi1dren.l When the 
tachyarrhythmia is reentrant, conversion by physio- 
logic, pharmacologic or electrical interruption of con- 
duction within a limb of the circuit is highly probable. 
Manipulation of physiologic vagal tone, the obvious- 
ly preferred mode, is not successful or feasible in a 
number of patients. Pharmacologic manipulation has 
been the most commonly used; however, digoxin and 
propranolol may require several hours for conver- 
sion. Intravenous administration of verapamil offers 
prompt termination2v3; however, in newborns it may 
be unsuccessful and carries the risk of hypotension, 
bradycardia, apnea and negative inotropy, especially 
in patients with coexisting congestive heart failure.4 
Electrical conversion by transvenous atria1 pacing or 
by direct current cardioversion requires invasive entry 
for 1 technique and frequently general anesthesia for 
the other. Recent reports from our institution5-7 as well 
as from otherssvg have demonstrated the usefulness, 
simplicity and safety of transesophageal atria1 burst 
pacing for conversion of reentrant tachyarrhythmias 
in infants and children. The technique, however, has 
not been included among the recent recommendations 
of several authorities.10-12 Our purpose, therefore, is to 
report our experience with transesophageal pacing in 
infants and children so that the technique may be 
more widely known. 
43 14f4 8-20 
43 5f2 3-10 
26 16 f 3 IO-20 
26 6f2 4-10 
The descrepancy in numbers between the arrhythmia and the pacing cycle 
length is related to incomplete data in a few patients. 
disease (9 transposition of the great arteries, 3 univen- 
tricular heart and 1 each of 6 different lesions). The 
older children were symptomatic with palpitations 
and the infants were symptomatic with tachypnea; 
1 infant had hydrops. Twenty-six children had su- 
praventricular tachycardia (SVT) and 17 had atrial 
flutter. For the purposes of this study, SVT was 
defined as narrow QRS tachycardia (except in pa- 
tients in whom preexisting bundle branch block was 
known], and by history or observation of abrupt initia- 
tion and termination and retrograde P waves with 
short RP intervals. 
Between April 15,1983, and December 33,1986,43 
children (25 boys and 18 girls] seen at our institution 
experienced 73 episodes of supraventricular tachy- 
arrhythmia. Three of these children were less than 1 
week of age; 7 children were 1 to 4 weeks of age; 9 
were 1 to 12 months of age; 13 were 1 to 30 years of age; 
and 11 were 10 years of age at the time of their initial 
episode. Among the 43 patients, 25 had no structural 
heart disease; 28 had associated postoperative heart 
Atrial flutter was defined by typical sawtooth-pat- 
tern P waves and variable atrioventricular block 
[leads II, III, aVF, V,) on the electrocardiogram. Fol- 
lowing the Mustard or Fontan operation, because of 
slow intraatrial conduction, the typical pattern is fre- 
quently absent in such patients. Atrial flutter in this 
group of patients was considered present if variable 
atrioventricular block was observed during the tachy- 
cardia and history or observation of abrupt initiation 
and termination was present. Of the 26 children with 
SVT, only 2 had associated structural heart disease; in 
contrast, 14 of the 17 children with atrial flutter had 
structural heart disease. Among the 25 children with 
SVT, 10 had preexcitation. Four patients, including 2 
infants, were converted from 6 different episodes as 
outpatients, avoiding hospitalization. In addition 4 pa- 
tients were converted after surgery while still in the 
intensive care unit. 
From the Division of Pediatric Cardiology, C.S. Mott Children’s To begin transesophageal pacing the patient is first 
Hospital, and the Department of Pediatrics, University of Michi- connected to a 3-lead standard electrogram. An intra- 
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age, a 4Fr bipolar (IO mm interelectrode distance] 
catheter is used [n = 49 episodes). For children 3 to 8 
years of age, a 6Fr endocardial pacing catheter (inter- 
electrode distance 2.9 cm) is used [n = 13). Children 8 
years and older are asked to swallow an electrode 
“pill” (n = 11). The 2 electrodes of the bipolar catheter 
are then connected to a recording amplifier and strip 
chart recorder. The electrodes are positioned close to 
the atrium by identifying the maximal atrial electro- 
gram, thus enhancing the atria1 signal, which may be 
small or within the QRS complex on the electrocar- 
diogram. The battery powered stimulator provides 
constant current pulses from 1 to 40 mA and 1 to 10 
ms in impulse amplitude and duration, respectively 
(Arzco Inc.). However, because of the experience in 
adults of excessive esophageal discomfort at stimulus 
strengths of >20 mA current and >lO ms pulse dura- 
tion, no attempt to pace patients at outputs in excess of 
those values is made. The threshold is measured at the 
minimal current and pulse duration required for con- 
stant atrial capture (Table I). Pacing is delivered in 
bursts of3 to zo seconds at 90% of the tachyarrhythmia 
cycle length, reducing the cycle length of each burst 
by 10 ms until either the arrhythmia is converted or 
refractoriness of the atria is reached. Details of the 
technique have been published previousJy.5-7 Other 
than one 18-month-old infant, no children under 2 
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FIGURE 1. A, 3 surface electrocardiographic leads (II, III, F) and 
simultaneous esophageal lead (ESO) demonstrating tachycardia at 
a heart rate of 273 beats/mln (cycle length 220 ms) in a l-monlh- 
old infant. Note the narrow QRS and the large atrial (a) electrogram 
equal to the ventricular (v) electrogram. B, pacing stimuli (s) are 
delivered at a cyclic length of 170 ms (353 beats/min) for 1.7 
seconds. Normal sinus rhythm appears after termination of pacing. 
years of age received sedation. Children aged 2 to 12 
years often expressed apprehension regarding pas- 
sage of the electrode catheter. In the 10 patients with 
continuing apprehension, sedation was accomplished 
with 75 to 100 mg/kg of chloral hydrate by mouth, an 
intramuscular injection (1 patient) of meperidine (I 
mg/kg), phenergan (0.5 mg/kg) and thorazine (0.5 mg/ 
kg], or diazepam (I to 5 mg) administered intravenous- 
ly. Because swallowing the pill electrode requires an 
awake, cooperative state, the II children using the pill 
did not receive [or request) sedation. 
The threshold could be determined in each patient 
before conversion. Ninety-one percent (42/46) of epi- 
sodes of supraventricular tachycardia were success- 
fully converted using this technique (Figure 1). In con- 
trast 74% (20/27) of episodes of atrial flutter were suc- 
cessfully converted to sinus rhythm (p = 0.06). Reasons 
for failure in the SVT group include failure to achieve 
capture in one 1%year-old patient dispite maximal 20 
mA and 10 ms stimulus strength, depleted stimulator 
battery in 2 infants with SVT and insufficient shorten- 
ing of the pacing cycle length in the fourth. AJJ these 
failures occurred early in our experience [within the 
first 25 trials) and most likely can be avoided by im- 
proved attention to technique. Reason for failure of 
conversion of atrial flutter by this technique has been 
reviewed previously. 6 Conversion of SVT was 
achieved with pacing cycle length of 78% of the SVT 
cycle length. The pacing cycle length required to con- 
vert the patients with atria1 flutter was slightly shorter 
at 71% of the atria1 flutter cycle length. The threshold 
for capture was not related to the patients’ age or size, 
the catheter used or the tachyarrhythmia converted, 
and did not differ between 2 separate episodes of 
tachyarrhythmia within a single patient with multiple 
episodes. Likewise, successful conversion was not re- 
lated to the presence or absence of heart disease either 
as a whole or within either tachyarrhythmia group@-7 
or to the presnce or absence of concurrent digoxin 
therapy. 
All verbally expressive children stated, when 
asked, that they felt a sensation of “heartburn” (sub- 
sternal discomfort) with each pacing discharge.5-7 In 
no patient did this sensation require termination of the 
procedure. No complications were noted in the in- 
fants and children in whom the 4Fr soft bipolar elec- 
trode catheter was used. Passage of the catheter into 
the trachea occurred in a Is-year-old girl at which 
point the catheter was withdrawn and correctly 
placed with successful conversion. One E-year-old 
girl bit through the fine wire of the pill electrode re- 
sulting in inadvertent pacing of her tongue. The pill 
was withdrawn, and exchanged for an endocardial 
pacing catheter with successful conversion. The next 
day she required repeat conversion and the pill was 
used successfully. One 1%year-old girl with a dual 
chamber pacemaker required programming of the 
pacemaker to the asynchronous (fixed rate] ventricu- 
lar mode during conversion of atrial flutter to avoid 
inhibition of the pacemaker and ventricular asystole. 
One 5-year-old boy experienced inadvertent inter- 
mittent ventricular pacing during an unsuccessful at- 
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tempt in converting atria1 flutter; no adverse effect 
was noted. Two 17-year-old boys immediately regur- 
gitated the pill electrode after swallowing (they are 
not included in the 43 study patients). 
Arrhythmias generated as a result of the technique 
occurred in 8 patients, all with atria1 flutter. Three 
patients (2 with transposition/Mustard] were convert- 
ed from atria1 flutter to atrial fibrillation; the fibrilla- 
tion persisted from 30 seconds to 45 minutes before 
self-extinguishing into sinus or a stable junctional 
rhythm. Three patients, all with transposition/Mus- 
tard, were converted from atria1 flutter to atrial fibril- 
lation or a faster flutter; these patients then received 
transthoracic direct current cardioversion under gen- 
eral anesthesia. No patient experienced hemodynam- 
ic deterioration or a ventricular response during atria1 
fibrillation faster than that observed during the origi- 
nal 211 atrioventricular block of atria1 flutter. One pa- 
tient with preexcitation but in atria1 flutter was con- 
verted to SVT; the latter tachycardia was immediately 
converted to sinus rhythm. The final patient is the one 
with inadvertent ventricular pacing; no sustained ar- 
rhythmia was initiated. Thus, in none of the patients 
did an adverse arrhythmia develop and, importantly, 
in 3 patients conversion to a stable rhythm was 
achieved by a transition through a period of nonsus- 
tained atria1 fibrillation. 
These data indicate that transesophageal atria1 pac- 
ing easily, predictably and safely converts reentrant 
supraventricular tachyarrhythmias to normal sinus 
rhythm. Although we and others have reported similar 
pediatric experience previously,5-g this more compre- 
hensive serial study underscores the usefulness and 
safety of this technique especi’ally in infants. Many 
authorities suggest that the first-line therapy for supra- 
ventricular tachycardia in infants and children is di- 
goxin, and that if the patient is hemodynamically im- 
paired, transthoracic direct current cardioversion.lO-l2 
Our data indicate that the delay inherent in digoxin or 
propranolol therapy, the risk of intravenous verapamil 
therapy and the transthoracic electrical discharge of- 
ten requiring general anesthesia can frequently be 
avoided by transesophageal atria1 pacing. 
Our experience outlines several special applica- 
tions of this technique in the young. First, although the 
time required to achieve access to the atria through the 
transesophageal route was not recorded, passage of 
the nasoesophageal catheter appeared to be quicker, 
simpler and less traumatic in an infant than establish- 
ing an intravenous route for pharmacologic agents. 
This difference in access is heightened by the poten- 
tially deleterious response to intravenous verapamil in 
the infant. Second, the use of a pill electrode requires, 
and may even encourage, a cooperative, participatory 
attitude in a reluctant older child or adolescent. The 
youngest patient to swallow the pill, which was used in 
all patients older than 10 years, was 8 years old. Third, 
the successful conversion of 74% of atria1 flutter epi- 
sodes suggests that this technique-perhaps because 
of the theoretical advantage of overdrive pacing for 
intraatrial reentrant arrhythmias when compared with 
most antiarrhythmic agents, and the smaller atria1 size 
of young subjects-may be particularly suitable for 
children with atria1 flutter.6 Finally these data address 
the role of transesophageal atria1 pacing in conversion 
of repeated episodes of either supraventricular tachy- 
cardia or atria1 flutter in a single patient. Clearly, burst 
pacing through any route is an acute therapeutic tech- 
nique and not a prophylactic one. Yet only 1 infant and 
two 8-year-old girls who were easily converted by 
transesophageal pacing immediately (within seconds] 
resumed the tachycardia. On the other hand, 19 of the 
43 children required 1 or more repeat conversions at 
an interval of several hours to 3 years. Importantly, 4 of 
the 10 infants required repeat converison during their 
initial hospitalization while drug treatment was under 
evaluation. Although this study did not randomly as- 
sign to the patient episode or type of SVT transeso- 
phageal atria1 pacing,.drug trials or direct current car- 
dioversion, it is nonetheless clear that atria1 pacing 
through the esophagus offers at least equally prompt 
and safe therapy compared with the other forms of 
converison, especially in the infant. 
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